Dimerix doubles as biotech lands licensing deal for kidney treatment
MELBOURNE: Dimerix shares more than doubled on Thursday after the biotechnology company announced a major
MELBOURNE: Dimerix shares more than doubled on Thursday after the biotechnology company announced a major
FEATURED
Global pilot shortage could mean push to raise retirement age
Dementia now the leading cause of death in the elderly
Chemist captured 42% of market for aged care
Trend for retirees to return to work is growing
Hop, skip and jump for strength and bone density says adherent
New affordable housing complex opens for seniors on fixed incomes
INNOVATION
